United Therapeutics reported $516M in Sales Revenues for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Amarin AMRN:US USD 89.88M 4.56M
Ardelyx ARDX:US USD 4.99M 2.46M
Baxter International BAX:US USD 3.77B 27M
Bayer BAYN:GR EUR 11.28B 1.54B
Biocryst Pharmaceuticals BCRX:US USD 75.83M 10.3M
Biogen BIIB:US USD 2.51B 80.6M
Biomarin Pharmaceutical BMRN:US USD 505.34M 28.45M
Emergent Biosolutions EBS:US USD 240M 2.7M
Esperion Therapeutics ESPR:US USD 18.98M 139K
Gilead Sciences GILD:US USD 7.04B 782M
GlaxoSmithKline GSK:LN GBP 782.9B 90B
Halozyme Therapeutics HALO:US USD 208.98M 56.61M
Insmed INSM:US USD 67.73M 2.51M
Intercept Pharmaceuticals ICPT:US USD 77.59M 5.83M
Intra Cellular Therapies ITCI:US USD 71.87M 16.29M
Johnson & Johnson JNJ:US USD 23.79B 229M
Lexicon Pharmaceuticals LXRX:US USD 39K 4K
Moderna Inc MRNA:US USD 3.36B 1.38B
Pfizer PFE:US USD 22.64B 5.1B
Ptc Therapeutics PTCT:US USD 217.13M 51.6M
Regeneron Pharmaceuticals REGN:US USD 2.94B 79M
Sangamo Biosciences SGMO:US USD 26.46M 2.92M
Sarepta Therapeutics SRPT:US USD 230.27M 3.22M
Seattle Genetics SGEN:US USD 510.3M 12.8M
Teva Pharmaceutical TEVA:IT USD 3.6B 191M
United Therapeutics UTHR:US USD 516M 49.1M
Vertex Pharmaceuticals VRTX:US USD 2.33B 138.1M